ARCHIVES

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

ACCC Recommends Cancer Act Changes

August 27, 1976

FDA Committee Approves Two NDAs, Blocks One, Hears NCI Toxicology Plan

June 15, 1979

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Letter to the Editors: Since 1992, Where Has All The OAM Grant Money Gone?

April 24, 1998

Assumption, Not Facts Form Base For Regulation Of Carcinogens, One Regulatory Coucil consultant Says; request for Study By NSA Denied

June 8, 1979

NIH Carcinogen Guidelines Offered

April 24, 1981